Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Abeloff

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Cancer Treatment Reports|January 1, 1983
Complications of treatment of small cell carcinoma of the lungM D Abeloff, J Klastersky, P D Drings, et al.
Journal of the National Cancer Institute|July 15, 1992
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized studyD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Journal of the National Cancer Institute|October 5, 1988
Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancerJ Whang-Peng, E C Lee, J D Minna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trialD C Tormey, R Gray, M D Abeloff, et al.
Investigational New Drugs|May 1, 1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancerD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Cancer|December 18, 2001
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)W J Gradishar, P Stephenson, D J Glover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatmentG Falkson, R S Gelman, K J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
The role of surgery in the management of selected patients with small-cell carcinoma of the lungR R Baker, D S Ettinger, J D Ruckdeschel, et al.
Investigational New Drugs|January 1, 1987
Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithineC A Griffin, M Slavik, S C Chien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup studyG T Budd, S Green, R M O'Bryan, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Cancer Treatment Reports|January 1, 1983
Complications of treatment of small cell carcinoma of the lungM D Abeloff, J Klastersky, P D Drings, et al.
Journal of the National Cancer Institute|July 15, 1992
Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized studyD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Journal of the National Cancer Institute|October 5, 1988
Deletion of 3(p14p23) in secondary erythroleukemia arising in long-term survivors of small cell lung cancerJ Whang-Peng, E C Lee, J D Minna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trialD C Tormey, R Gray, M D Abeloff, et al.
Investigational New Drugs|May 1, 1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancerD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Cancer|December 18, 2001
A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188)W J Gradishar, P Stephenson, D J Glover, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatmentG Falkson, R S Gelman, K J Pandya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1987
The role of surgery in the management of selected patients with small-cell carcinoma of the lungR R Baker, D S Ettinger, J D Ruckdeschel, et al.
Investigational New Drugs|January 1, 1987
Phase I trial and pharmacokinetic study of intravenous and oral alpha-difluoromethylornithineC A Griffin, M Slavik, S C Chien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup studyG T Budd, S Green, R M O'Bryan, et al.
Pageof 9